HSBC Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.55M | Buy |
97,197
+45,665
| +89% | +$1.67M | ﹤0.01% | 1004 |
|
2025
Q1 | $1.86M | Buy |
51,532
+4,016
| +8% | +$145K | ﹤0.01% | 1141 |
|
2024
Q4 | $1.97M | Buy |
47,516
+31,416
| +195% | +$1.31M | ﹤0.01% | 1169 |
|
2024
Q3 | $890K | Buy |
+16,100
| New | +$890K | ﹤0.01% | 1419 |
|
2024
Q2 | – | Sell |
-17,349
| Closed | -$810K | – | 2676 |
|
2024
Q1 | $810K | Sell |
17,349
-2,114
| -11% | -$98.7K | ﹤0.01% | 1515 |
|
2023
Q4 | $931K | Sell |
19,463
-7,512
| -28% | -$359K | ﹤0.01% | 1420 |
|
2023
Q3 | $958K | Buy |
26,975
+2,662
| +11% | +$94.6K | ﹤0.01% | 1330 |
|
2023
Q2 | $1.13M | Sell |
24,313
-2,699
| -10% | -$126K | ﹤0.01% | 1309 |
|
2023
Q1 | $1.08M | Sell |
27,012
-45,468
| -63% | -$1.82M | ﹤0.01% | 1363 |
|
2022
Q4 | $3.28M | Buy |
72,480
+61,631
| +568% | +$2.79M | ﹤0.01% | 1184 |
|
2022
Q3 | $457K | Sell |
10,849
-2,884
| -21% | -$121K | ﹤0.01% | 1809 |
|
2022
Q2 | $810K | Sell |
13,733
-935
| -6% | -$55.1K | ﹤0.01% | 1685 |
|
2022
Q1 | $1.07M | Buy |
14,668
+8,231
| +128% | +$600K | ﹤0.01% | 1594 |
|
2021
Q4 | $547K | Sell |
6,437
-397
| -6% | -$33.7K | ﹤0.01% | 1963 |
|
2021
Q3 | $611K | Sell |
6,834
-1,838
| -21% | -$164K | ﹤0.01% | 1712 |
|
2021
Q2 | $833K | Buy |
8,672
+4,463
| +106% | +$429K | ﹤0.01% | 1497 |
|
2021
Q1 | $480K | Sell |
4,209
-5,753
| -58% | -$656K | ﹤0.01% | 1663 |
|
2020
Q4 | $1.4M | Buy |
9,962
+4,699
| +89% | +$659K | ﹤0.01% | 1161 |
|
2020
Q3 | $445K | Buy |
+5,263
| New | +$445K | ﹤0.01% | 1625 |
|
2020
Q1 | – | Sell |
-25,424
| Closed | -$1.1M | – | 2415 |
|
2019
Q4 | $1.1M | Sell |
25,424
-3,024
| -11% | -$131K | ﹤0.01% | 1308 |
|
2019
Q3 | $1.22M | Buy |
+28,448
| New | +$1.22M | ﹤0.01% | 1318 |
|
2018
Q2 | – | Sell |
-4,167
| Closed | -$213K | – | 2019 |
|
2018
Q1 | $213K | Buy |
+4,167
| New | +$213K | ﹤0.01% | 1832 |
|
2017
Q1 | – | Sell |
-8,645
| Closed | -$607K | – | 1992 |
|
2016
Q4 | $607K | Buy |
+8,645
| New | +$607K | ﹤0.01% | 1280 |
|
2015
Q3 | – | Sell |
-2,141
| Closed | -$219K | – | 1762 |
|
2015
Q2 | $219K | Buy |
+2,141
| New | +$219K | ﹤0.01% | 1552 |
|